$30.17
$0.00 (0.00%)
End-of-day quote: 05/31/2024
NasdaqCM:CORT

Corcept Therapeutics Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$482.38M $401.86M $365.98M $353.87M $306.49M $251.25M $159.20M $26.55M $10.36M $3.31M $0.00M $0.00M $0.03M $0.21M $0.48M $0.29M $0.00M $0.00M
GM % Gross Margin %
98.66% 98.66% 98.56% 98.42% 98.20% 97.92% 97.77% 96.68% 98.62% 97.25% 0.00% 0.00% 100.00% 100.00% 100.00% 100.00% 0.00% 0.00%
OM Operating Margin
22.24% 28.03% 34.01% 36.23% 36.41% 35.62% 33.20% -104.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share
$0.00 $0.94 $0.87 $1.19 $1.17 $1.09 $0.85 $0.51 $-0.22 $-0.36 $-0.33 $-0.39 $-0.38 $-0.38 $-0.43 $-0.34 $-1.09 $-0.89 $-0.84
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0.00% 0.00% 0.00% 0.00% 0.00% -0.00% -0.00% -0.00% 0 0 0 0 0 0 0 0
Sha. Shares
103.41m 107.84m 105.94m 116.74m 114.55m 115.03m 114.72m 101.4m 99.85m 99.81m 84.23m 72.4m 62.48m 49.76m 39.55m 25.73m 22.7m 22.69m
OCF Operating Cash Flow
$127.04M $120.32M $167.89M $151.97M $136.12M $115.67M $60.94M $-27.38M $-37.06M $-36.02M $-27.40M $-22.29M $-17.97M $-18.36M $-10.96M $-23.24M $-17.23M $-13.72M
FCF Free Cash Flow
$163.31M $119.91M $167.42M $150.71M $135.03M $115.37M $60.52M $-27.55M $-37.19M $-36.17M $-27.43M $-22.29M $0.00M $-18.37M $0.00M $0.00M $0.00M $0.00M
FCFS Free Cash Flow Per Share
$1.23 $1.12 $1.45 $1.31 $1.18 $1.00 $0.53 $-0.27 $-0.37 $-0.39 $-0.33 $-0.33 $-0.34 $-0.39 $-0.32 $-1.02 $-0.76 $-0.74